52.09 USD
+1.43
2.82%
At close Updated Nov 11, 12:54 PM EST
1 day
2.82%
5 days
7.11%
1 month
6.74%
3 months
10.34%
6 months
2.02%
Year to date
8.09%
1 year
2.9%
5 years
0.91%
10 years
15.65%
 

About: Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Employees: 82,878

0
Funds holding %
of 7,512 funds
0
Analysts bullish %
of 1 analysts
0
Positive news %
of 23 articles
Price charts implemented using Lightweight Charts™